Interpretation on the 2024 Chinese Guidelines for the Diagnosis and Treatment of Rheumatoid Arthritis
10.12290/xhyxzz.2024-1018
- VernacularTitle:《2024中国类风湿关节炎诊疗指南》解读
- Author:
Nan JIANG
1
;
Xinping TIAN
1
;
Xiaofeng ZENG
1
Author Information
1. 中国医学科学院北京协和医院风湿免疫科国家皮肤与免疫疾病临床医学研究中心风湿免疫病学教育部重点实验室,北京 100730;中国医学科学院北京协和医院疑难重症及罕见病国家重点实验室,北京 100730
- Publication Type:Journal Article
- Keywords:
rheumatoid arthritis;
diagnosis;
therapy;
guideline interpretation
- From:
Medical Journal of Peking Union Medical College Hospital
2025;16(1):28-34
- CountryChina
- Language:Chinese
-
Abstract:
Rheumatoid Arthritis(RA)is a critical disease that endangers the health of the Chinese pop-ulation.At present,there are still many deficiencies in the diagnosis and treatment of RA in China.The 2024 Chinese Guidelines for the Diagnosis and Treatment of Rheumatoid Arthritis addresses 10 important clinical issues in the diagnosis and treatment of RA,and provides evidence-based recommendations based on the latest domes-tic and international literature,with consideration of the actual situation of RA diagnosis and treatment in China.The guidelines comprehensively cover the diagnosis of RA,imaging examinations,treatment goals,follow-up monitoring,initial treatment plans,treatment adjustments,the application of glucocorticoids,drug tapering,and health education.They will promote the RA diagnosis and treatment levels and improve the prog-nosis of RA patients in China.
